🔗 Share this article

Chancellor Reeves has revealed she is planning "specific measures to deal with cost of living issues" in the upcoming financial statement.

Speaking to the BBC, she emphasized that lowering price rises is a joint duty of both the administration and the Bank of England.

The UK's inflation rate is expected to be the highest among the Group of Seven developed nations this year and next.

Possible Energy Cost Interventions

Reports indicate the government could take action to lower energy bills, for instance by reducing the present 5% rate of VAT applied on energy supplies.

An additional option is to cut some of the regulatory levies currently included in bills.

Budgetary Constraints and Analyst Predictions

The administration will obtain the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much room there is for such measures.

The view from the majority of economists is that Reeves will have to introduce tax rises or budget cuts in order to meet her self-imposed debt limits.

Previously on Thursday, analysis indicated there was a £22 billion shortfall for the chancellor to resolve, which is at the more modest range of expectations.

"There's a collective responsibility between the Bank of England and the government to further reduce some of the drivers of inflation," Reeves informed the BBC in Washington, at the annual meetings of the IMF and World Bank.

Tax Pledges and International Issues

While a great deal of the focus has been on probable tax increases, the chancellor said the most recent figures from the OBR had not altered her commitment to election pledges not to increase tax levels on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable global environment" with rising international and commercial concerns for the fiscal tax moves, likely to be focused on those "wealthiest."

International Trade Disputes

Referring to concerns about the UK's economic relations with China she said: "Our national security invariably take priority."

Last week's announcement by China to tighten trade restrictions on critical minerals and other resources that are crucial for high-technology manufacturing led US President the US President to propose an additional 100% import tax on imports from the Asian country, increasing the prospect of an all-out commercial conflict between the two global powers.

The American finance chief labeled China's action "commercial pressure" and "a international production control attempt."

Asked about accepting the US offer to participate in its conflict with the Asian nation, the Chancellor said she was "extremely troubled" by China's actions and encouraged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "damaging for the international commerce and creates additional challenges."

"I believe there are fields where we should confront Chinese policies, but there are also valuable opportunities to sell into Chinese markets, including financial services and other sectors of the economic system. We've got to achieve that equilibrium correct."

The chancellor also stated she was collaborating with other major economies "on our own essential resources strategy, so that we are reduced dependence."

NHS Drug Costs and Funding

The Chancellor also acknowledged that the price the National Health Service pays for pharmaceuticals could rise as a result of current negotiations with the US government and its pharmaceutical firms, in exchange for lower tariffs and funding.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either pausing or scrapping investments in the UK, with some blaming the modest returns they are obtaining.

Recently, the Science Minister said the price the NHS spends on medicines would need to increase to halt businesses and pharmaceutical investment departing from the UK.

Reeves stated to media: "It has been observed as a result of the cost structure, that drug testing, innovative medicines have not been available in the UK in the manner that they are in other continental states."

"We want to guarantee that people getting care from the National Health Service are able to obtain the best life-saving drugs in the world. And so we are reviewing these issues, and... aiming to obtain additional investment into Britain."